© 2026 Aureon Bioscience
KLOW- BPC-157 + TB-500 + Ghk-Cu + KPV 80mg
$375.00
Skip to product information
KLOW- BPC-157 + TB-500 + Ghk-Cu + KPV 80mg
The Klow Blend combines four research peptides, BPC-157, TB-500, KPV, and GHK-Cu, formulated for studies on cellular repair, immune modulation, and extracellular matrix regulation. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide and growth factor pathways. TB-500, a segment of Thymosin Beta-4, regulates actin polymerization and tissue remodeling. KPV, derived from the C-terminal region of alpha-melanocyte-stimulating hormone, modulates NF-κB and cytokine signaling. GHK-Cu, a copper(II)-complexed tripeptide, influences metalloprotein activity and redox balance. Together, these peptides are used in research examining regeneration, inflammation, and peptide–metal interaction mechanisms.
For research use only. Not for human consumption.
Properties
1. Basic Information
2. Structural Properties
BPC-157: 15 amino acid linear peptide, stable partial sequence of body protection compound
TB-500: Synthetic fragment of Thymosin Beta-4 (Ac-SDKP), actin-binding peptide
GHK-Cu: Tripeptide-copper complex (Gly-His-Lys), naturally occurring in human plasma
KPV: Tripeptide (Lys-Pro-Val), C-terminal fragment of alpha-MSH
3. Solubility
4. Stability
Thermal Stability: Store below 4°C after reconstitution; sensitive to repeated freeze-thaw cycles
Proteolytic Stability: BPC-157 highly stable to acid hydrolysis; other components moderately sensitive to proteases
Storage: Store lyophilized at −20°C; reconstituted solution stable up to 30 days at 2–8°C
5. Chemical Reactivity
GHK-Cu chelates copper ions; avoid contact with metal surfaces during preparation
BPC-157 contains no methionine; low oxidation risk
KPV tripeptide is chemically stable under standard storage conditions
TB-500 fragment contains actin-binding domain; handle with care to avoid aggregation
6. Other Properties
- Name: KLOW (BPC-157 + TB-500 + GHK-Cu + KPV Blend)
- Type: Multi-peptide research blend
- Components: Body Protection Compound-157, Thymosin Beta-4 Fragment, Copper Tripeptide-1, Lysine-Proline-Valine
- Total Weight: 80mg combined
- Formula: Combination of C₆₂H₉₈N₁₆O₂₂ (BPC-157) + C₄₅H₇₂N₁₀O₁₂ (TB-500 fragment) + C₁₄H₂₃CuN₆O₄ (GHK-Cu) + C₁₅H₂₉N₃O₄ (KPV)
2. Structural Properties
BPC-157: 15 amino acid linear peptide, stable partial sequence of body protection compound
TB-500: Synthetic fragment of Thymosin Beta-4 (Ac-SDKP), actin-binding peptide
GHK-Cu: Tripeptide-copper complex (Gly-His-Lys), naturally occurring in human plasma
KPV: Tripeptide (Lys-Pro-Val), C-terminal fragment of alpha-MSH
3. Solubility
- All components soluble in bacteriostatic water
- GHK-Cu may impart blue-green color upon reconstitution due to copper chelation
- Stable at neutral to slightly acidic pH
- Supplied as lyophilized powder for reconstitution
4. Stability
Thermal Stability: Store below 4°C after reconstitution; sensitive to repeated freeze-thaw cycles
Proteolytic Stability: BPC-157 highly stable to acid hydrolysis; other components moderately sensitive to proteases
Storage: Store lyophilized at −20°C; reconstituted solution stable up to 30 days at 2–8°C
5. Chemical Reactivity
GHK-Cu chelates copper ions; avoid contact with metal surfaces during preparation
BPC-157 contains no methionine; low oxidation risk
KPV tripeptide is chemically stable under standard storage conditions
TB-500 fragment contains actin-binding domain; handle with care to avoid aggregation
6. Other Properties
- Synergistic blend: Each component targets distinct molecular pathways in research models
- BPC-157: Studied in relation to growth factor expression and cytoprotective signaling
- TB-500: Associated with actin dynamics and cellular migration in experimental systems
- GHK-Cu: Investigated for effects on collagen synthesis and antioxidant gene expression
- KPV: Examined in relation to anti-inflammatory signaling pathways
Description
KLOW is a multi-peptide research blend combining BPC-157, TB-500 (Thymosin Beta-4 fragment), GHK-Cu, and KPV. Each component has been described independently in the scientific literature within distinct experimental research contexts. Publications discussing these peptides address them in the context of cellular signaling, structural protein dynamics, and molecular communication within experimental systems.
Reports involving the individual components describe molecular interactions with distinct cellular targets under defined experimental conditions. Observations of signaling components and molecular interactions are limited to non-clinical research settings and are reported as descriptive findings within cellular and animal model studies.
All references to the components of KLOW are confined to mechanistic and observational research contexts and do not extend beyond laboratory-based investigation.
In the scientific literature, the individual components of KLOW have each been referenced in non-clinical research involving cellular assays and animal model studies. These publications describe experimental contexts in which molecular interactions, signaling components, and pathway-associated markers were observed and recorded.
Reported research contexts include examination of:
- BPC-157: Growth factor receptor-associated signaling components in experimental models
- BPC-157: Cytoprotective pathway markers observed in cellular and animal systems
- TB-500: Actin-binding dynamics and cellular migration markers in experimental systems
- GHK-Cu: Collagen synthesis-associated gene expression patterns evaluated in cellular models
- GHK-Cu: Antioxidant pathway-associated molecular markers in laboratory settings
- KPV: Anti-inflammatory signaling pathway components observed in experimental models
All reported applications are confined to descriptive investigation within controlled laboratory research environments.
Mechanistic discussions in preclinical publications describe each component in relation to distinct intracellular signaling frameworks. The combination of components in KLOW is formulated to provide researchers with a multi-target blend for experimental use. All pathway-related descriptions are restricted to non-clinical research contexts and do not imply functional outcomes.
KLOW is supplied as a research-grade multi-peptide material. Identity and composition of each component have been reported as characterized using analytical techniques commonly applied to peptide research materials, including chromatographic and mass spectrometric methods. Individual laboratories determine handling, storage, and analytical verification parameters in accordance with internal research protocols.
COA
Storage
All of our products are manufactured using the Lyophilization (Freeze Drying) process, which ensures that our products remain 100% stable for shipping for up to 3-4 months. Once the peptides are reconstituted (mixed with bacteriostatic water), they must be stored in the fridge to maintain stability. After reconstitution, the peptides will remain stable for up to 30 days.
Lyophilization is a unique dehydration process, also known as cryodesiccation, where the peptides are frozen and then subjected to low pressure. This causes the water in the peptide vial to sublimate directly from solid to gas, leaving behind a stable, crystalline white structure known as lyophilized peptide. The puffy white powder can be stored at room temperature until you're ready to reconstitute it with bacteriostatic water.
Once peptides have been received, it is imperative that they are kept cold and away from light. If the peptides will be used immediately, or in the next several days, weeks or months, short-term refrigeration under 4°C (39°F) is generally acceptable. Lyophilized peptides are usually stable at room temperatures for several weeks or more, so if they will be utilized within weeks or months such storage is typically adequate.
For longer term storage (several months to years) it is more preferable to store peptides in a freezer at -80°C (-112°F). When storing peptides for months or even years, freezing is optimal in order to preserve the peptide's stability.
Lyophilization is a unique dehydration process, also known as cryodesiccation, where the peptides are frozen and then subjected to low pressure. This causes the water in the peptide vial to sublimate directly from solid to gas, leaving behind a stable, crystalline white structure known as lyophilized peptide. The puffy white powder can be stored at room temperature until you're ready to reconstitute it with bacteriostatic water.
Once peptides have been received, it is imperative that they are kept cold and away from light. If the peptides will be used immediately, or in the next several days, weeks or months, short-term refrigeration under 4°C (39°F) is generally acceptable. Lyophilized peptides are usually stable at room temperatures for several weeks or more, so if they will be utilized within weeks or months such storage is typically adequate.
For longer term storage (several months to years) it is more preferable to store peptides in a freezer at -80°C (-112°F). When storing peptides for months or even years, freezing is optimal in order to preserve the peptide's stability.
